EUDA

EUDA Health Holdings Limited

EUDA Health Holdings Limited (EUDA) is rated C+ (2.6/5) on Deltasharpe Prism, scored against Real Estate sector peers. Its strongest pillar is Momentum (B-); its weakest is Profitability (D+).

Quantitative Factor Evaluation • Updated

Overall Rating
2.6 / 5.0
C+
Value
B-
Factor Score 2.9 / 5.0
Growth
B-
Factor Score 3.0 / 5.0
Profitability
D+
Factor Score 1.6 / 5.0
Momentum
B-
Factor Score 3.1 / 5.0
Revisions
C
Factor Score 2.4 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio 9.2
EV / EBITDA -23.8
Rev Growth YoY 13.4%
Gross Margin 47.6%
Price Return 3M 10.2%
Price Return 12M -78.6%
Catalyst Signal 0.00
Market Cap $43.9M
TTM Revenue $7.2M
Price / Sales 6.1
ROE -211.4%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-11 B- (2.9) B- (3.0) D+ (1.6) B- (3.1) C (2.4) C+ (2.6)
2026-11-04 C+ (2.8) C+ (2.8) D+ (1.6) B- (2.9) C (2.4) C (2.5)
2026-10-28 C+ (2.8) C+ (2.7) D+ (1.5) C+ (2.5) C (2.4) C (2.4)
2026-10-21 C+ (2.7) C+ (2.7) D+ (1.5) B (3.3) C (2.4) C+ (2.5)
2026-10-14 C (2.3) C+ (2.7) D+ (1.5) B (3.4) C (2.3) C (2.4)
Page 1 of 4